CollPlant Biotechnologies has announced encouraging non-clinical results for its photocurable regenerative dermal and soft tissue filler. The company is preparing for clinical trials, a key step toward transforming the future of aesthetic and regenerative treatments. A new era in filler technology CollPlant Biotechnologies’ innovation stands out for combining precision contouring, strong structural support, and natural tissue regeneration in a single ...
DataM Intelligence reports that the breast reconstruction market was valued at USD 574.33 million in 2022. It is expected to grow at a 6.4% CAGR, reaching USD 934.30 million by 2030. Breast reconstruction involves various surgical techniques designed to restore the shape and appearance of the breast following mastectomy, lumpectomy, or congenital anomalies. These techniques include implant-based reconstruction, autologous tissue ...